celgene – HedgeChatter

Biotech Stocks Technical Study — Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma

LONDON, March 18, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Celgene Corporation (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI), Amarin Corporation PLC (NASDAQ: AMRN), and Synergy Pharmaceuticals Inc. (NASDAQ: SGYP). Free research report on Orexigen Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Orexigen%20Therapeutics&d=18-Mar-2015&s=OREX. […]

March 18, 2015 amarin, celgene, cfa, investor, investor-edge, nasdaq, pdl, pharmaceuticals, plc, rsi, stock, therapeutics Comments Off read more

3 Biotech Stocks Wall Street Loves

Source: Wikimedia Commons .How can you know when Wall Street really loves a stock? One key sign is how many of the analysts covering the stock maintain buy ratings. Another tell-tale indicator is the price targets these analysts give for the stock. The higher the target is above the current share price, the more highly the analysts view the stock.Analysts […]

March 16, 2015 celgene, european, gilead, motley, revlimid, sciences, soliris, stock Comments Off read more

The 4 Biggest Biotech Stocks In The Market

View gallery.When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of […]

March 11, 2015 amgen, celgene, company, gen, gilead, king, market, stocks Comments Off read more

The 4 Biggest Biotech Stocks In The Market – Celgene Corporation …

When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]

March 11, 2015 ByChristian Tharp CMT AMGN, biib, biogen, celgene, corporation, current, GILD, industry, street Comments Off read more

The Best Stock To Buy When Biotech Stocks Tumble (CELG)

There’s nothing better than getting a great value — and let’s face it, when the market tumbles, often great stocks get crushed too. That could end up being particularly true in biotech. Since 2013, the industry’s return has tripled the S&P 500’s return, and that may mean that with the market slipping lately, biotech’s leading names — including Celgene — […]

March 10, 2015 ByInvestopedia capital, celgene, history, industry, markets, otezla, pomalyst, sales, year Comments Off read more

3 Biotech Stocks We've Fallen For

Source: Flickr user Simon & His Camera .Love is in the air. At least it is for three of our top Motley Fool healthcare contributors. Each has a crush on a different biotech stock darling, and they all find their pick attractive for different reasons. Read on to learn which biotech companies have caught the fancy of these three contributors, […]

February 7, 2015 alzheimer, biogen, camera, celgene, flickr, king, nasdaq, RNA Comments Off read more

3 Biotech Stocks to Buy in February

When it comes to figuring out the best stocks to buy in any given month or year, crystal balls can be hazy, but our top Motley Fool contributors have scoured SEC filings, read industry trade journals, and crunched numbers to uncover three biotech stocks that they think could be among the top stocks to buy in February.Source: BioMarin.: The road […]

February 2, 2015 celgene, fda, fresenius, group, market, motley, motley-fool, nasdaq, revlimid, road, street, technologies Comments Off read more

3 Biotech Giants That Shouldn't Pay a Dividend

It’s been shown that dividend-paying stocks outperform their non-dividend paying counterparts, but focusing on dividends may not be the best strategy when it comes to big biotech stocks. Read on to learn why three Motley Fool contributors don’t think it makes sense for these big biotech companies to pay investors a dividend.Cheryl Swanson : Take a little trip through history […]

January 31, 2015 amgen, biogen, celgene, gilead, gilead-sciences, group, hiv, king, motley, nasdaq, street Comments Off read more

The 5 Biggest Biotech Stocks – SPDR Gold Shares ETF … – Benzinga

Biotech is big, and the industry has been big for quite some time.As a matter of fact, biotechnology has been the second-best performing industry over the last two years.Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.However, at the end of the day, the big biotechs […]

January 20, 2015 ByChristian Tharp CMT biib, CELG, celgene, corporation, gen, nasdaq, regeneron, regn Comments Off read more

5 Tiny Biotech Stocks to Own in 2015

Biotech stocks are among the market’s riskiest, but investors willing to accept the potential for pipeline failure might consider owning these five small-cap biotech stocks in 2015. All five have intriguing therapies in late-stage clinical trials, and three have high-profile big-cap partners.Source: Flickr user Carlos Gracia1. Proven performerInsys Therapeutics is already rewarding shareholders with rapid sales growth and profitability, but […]

January 17, 2015 acceleron, achillion, celgene, flickr, insys, king, llc, lucentis, motley, sciences Comments Off read more